Compare TCBK & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCBK | LMAT |
|---|---|---|
| Founded | 1975 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1995 | 2006 |
| Metric | TCBK | LMAT |
|---|---|---|
| Price | $60.06 | $100.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $54.60 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 435.0K | 347.2K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.87% | 0.93% |
| EPS Growth | 6.94 | ★ 30.57 |
| EPS | ★ 1.04 | 0.68 |
| Revenue | $53,445,000.00 | ★ $249,602,000.00 |
| Revenue This Year | $12.03 | $14.21 |
| Revenue Next Year | $4.47 | $8.88 |
| P/E Ratio | ★ $57.50 | $149.54 |
| Revenue Growth | 4.12 | ★ 13.53 |
| 52 Week Low | $39.84 | $79.01 |
| 52 Week High | $61.71 | $118.01 |
| Indicator | TCBK | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 66.73 | 54.85 |
| Support Level | $48.57 | $82.47 |
| Resistance Level | N/A | $114.98 |
| Average True Range (ATR) | 1.45 | 3.48 |
| MACD | 0.49 | 0.17 |
| Stochastic Oscillator | 80.69 | 55.77 |
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.